MedTrace Logo

Visual and Refractive Outcomes of a New Diffractive Trifocal Toric Intraocular Lens

NCT04940793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2021-06-28

No results posted yet for this study

Summary

The purpose of this study is to investigate the visual performance and refractive predictability with the diffractive toric Finevision POD FT IOL. Predicted and achieved visual outcomes, visual performance at near, intermediate and far distance as well as photic phenomena, rotational stability and spectacle independence will be investigated. The follow-up period is 3 months after which vision and refraction should have stabilized.

Conditions

  • Cataract

Interventions

DEVICE

POD FT

Cataract surgery

Sponsors & Collaborators

  • Beaver-Visitec International, Inc.

    lead INDUSTRY

Principal Investigators

  • Filomena Ribeiro, MD, PhD, FEBO · Hospital da Luz

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-18
Primary Completion
2019-01-23
Completion
2019-01-23

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04940793 on ClinicalTrials.gov